Mannheim, Germany

Jürgen Krauss

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Wilhelmsfeld, DE (2014)
  • Mannheim, DE (2017 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jürgen Krauss: Innovator in Antibody and Molecular Delivery Technologies

Introduction

Jürgen Krauss is a notable inventor based in Mannheim, Germany. He has made significant contributions to the fields of immunotherapy and molecular delivery systems. With a total of 4 patents, his work focuses on innovative solutions for treating viral infections and enhancing cellular delivery mechanisms.

Latest Patents

Krauss's latest patents include a topical application for an anti-HSV antibody. This invention describes an anti-HSV antibody or an antigen-binding fragment for treating acute infections caused by HSV-1 or HSV-2. The antibody is designed for topical administration and is included in a pharmaceutical composition with acceptable excipients. Another significant patent is a construct for delivering a molecule into the cytoplasm of a cell. This construct comprises a targeting moiety, a fusogenic moiety derived from dengue virus glycoprotein E, and a molecule intended for cytoplasmic delivery. The patent also outlines a pharmaceutical composition and a kit for effective delivery of therapeutic and detectable moieties.

Career Highlights

Throughout his career, Jürgen Krauss has worked with various companies, including Lutana GmbH and Heiselberg Immunotherapeutics GmbH. His expertise in immunotherapy and molecular delivery has positioned him as a key figure in these organizations.

Collaborations

Krauss has collaborated with notable colleagues such as Michaela Arndt and Michael Roggendorf. Their combined efforts have contributed to advancements in the field of immunotherapy and molecular delivery systems.

Conclusion

Jürgen Krauss is a distinguished inventor whose work in antibody and molecular delivery technologies has the potential to significantly impact medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…